CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 8-K Event Shareholder vote results
- 4 Planned sale SVP, Chief Legal Officer sold 12,016 shares at $1.26 ($15,140)
- 4 Planned sale SVP, Chief Operating Officer sold 34,840 shares at $1.26 ($43,898)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale SVP, Chief Medical Officer sold 27,000 shares at $1.15 ($31,050)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event New debt or obligation
- 8-K Event Material agreement
- 8-K Event Regulation FD disclosure · Other events
Page 7 of 45 · 886 filings